Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage

Intracerebral hemorrhage (ICH) is the most common form of hemorrhagic stroke, accounting for 15% of all strokes. ICH has the highest acute mortality and the worst long-term prognosis of all stroke subtypes. Unfortunately, the dearth of clinically effective treatment options makes ICH the least treat...

Full description

Saved in:
Bibliographic Details
Main Authors: Melanie D. King, Wittstatt A. Whitaker-Lea, James M. Campbell, Cargill H. Alleyne, Krishnan M. Dhandapani
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2014/495817
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552408451907584
author Melanie D. King
Wittstatt A. Whitaker-Lea
James M. Campbell
Cargill H. Alleyne
Krishnan M. Dhandapani
author_facet Melanie D. King
Wittstatt A. Whitaker-Lea
James M. Campbell
Cargill H. Alleyne
Krishnan M. Dhandapani
author_sort Melanie D. King
collection DOAJ
description Intracerebral hemorrhage (ICH) is the most common form of hemorrhagic stroke, accounting for 15% of all strokes. ICH has the highest acute mortality and the worst long-term prognosis of all stroke subtypes. Unfortunately, the dearth of clinically effective treatment options makes ICH the least treatable form of stroke, emphasizing the need for novel therapeutic targets. Recent work by our laboratory identified a novel role for the necroptosis inhibitor, necrostatin-1, in limiting neurovascular injury in tissue culture models of hemorrhagic injury. In the present study, we tested the hypothesis that necrostatin-1 reduces neurovascular injury after collagenase-induced ICH in mice. Necrostatin-1 significantly reduced hematoma volume by 54% at 72 h after-ICH, as compared to either sham-injured mice or mice administered an inactive, structural analogue of necrostatin-1. Necrostatin-1 also limited cell death by 48%, reduced blood-brain barrier opening by 51%, attenuated edema development to sham levels, and improved neurobehavioral outcomes after ICH. These data suggest a potential clinical utility for necrostatin-1 and/or novel necroptosis inhibitors as an adjunct therapy to reduce neurological injury and improve patient outcomes after ICH.
format Article
id doaj-art-02dc788543ab4e2bb84d2871f755d444
institution Kabale University
issn 1687-8876
1687-8884
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-02dc788543ab4e2bb84d2871f755d4442025-02-03T05:58:39ZengWileyInternational Journal of Cell Biology1687-88761687-88842014-01-01201410.1155/2014/495817495817Necrostatin-1 Reduces Neurovascular Injury after Intracerebral HemorrhageMelanie D. King0Wittstatt A. Whitaker-Lea1James M. Campbell2Cargill H. Alleyne3Krishnan M. Dhandapani4Department of Neurosurgery, Medical College of Georgia, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USADepartment of Neurosurgery, Medical College of Georgia, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USADepartment of Neurosurgery, Medical College of Georgia, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USADepartment of Neurosurgery, Medical College of Georgia, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USADepartment of Neurosurgery, Medical College of Georgia, Georgia Regents University, 1120 15th Street, Augusta, GA 30912, USAIntracerebral hemorrhage (ICH) is the most common form of hemorrhagic stroke, accounting for 15% of all strokes. ICH has the highest acute mortality and the worst long-term prognosis of all stroke subtypes. Unfortunately, the dearth of clinically effective treatment options makes ICH the least treatable form of stroke, emphasizing the need for novel therapeutic targets. Recent work by our laboratory identified a novel role for the necroptosis inhibitor, necrostatin-1, in limiting neurovascular injury in tissue culture models of hemorrhagic injury. In the present study, we tested the hypothesis that necrostatin-1 reduces neurovascular injury after collagenase-induced ICH in mice. Necrostatin-1 significantly reduced hematoma volume by 54% at 72 h after-ICH, as compared to either sham-injured mice or mice administered an inactive, structural analogue of necrostatin-1. Necrostatin-1 also limited cell death by 48%, reduced blood-brain barrier opening by 51%, attenuated edema development to sham levels, and improved neurobehavioral outcomes after ICH. These data suggest a potential clinical utility for necrostatin-1 and/or novel necroptosis inhibitors as an adjunct therapy to reduce neurological injury and improve patient outcomes after ICH.http://dx.doi.org/10.1155/2014/495817
spellingShingle Melanie D. King
Wittstatt A. Whitaker-Lea
James M. Campbell
Cargill H. Alleyne
Krishnan M. Dhandapani
Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
International Journal of Cell Biology
title Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
title_full Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
title_fullStr Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
title_full_unstemmed Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
title_short Necrostatin-1 Reduces Neurovascular Injury after Intracerebral Hemorrhage
title_sort necrostatin 1 reduces neurovascular injury after intracerebral hemorrhage
url http://dx.doi.org/10.1155/2014/495817
work_keys_str_mv AT melaniedking necrostatin1reducesneurovascularinjuryafterintracerebralhemorrhage
AT wittstattawhitakerlea necrostatin1reducesneurovascularinjuryafterintracerebralhemorrhage
AT jamesmcampbell necrostatin1reducesneurovascularinjuryafterintracerebralhemorrhage
AT cargillhalleyne necrostatin1reducesneurovascularinjuryafterintracerebralhemorrhage
AT krishnanmdhandapani necrostatin1reducesneurovascularinjuryafterintracerebralhemorrhage